quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:10:28·51d
SECFiling
Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

CPIX· Cumberland Pharmaceuticals Inc.
Health Care
Original source

Companies

  • CPIX
    Cumberland Pharmaceuticals Inc.
    Health Care

Related

  • SEC1d
    SEC Form DEFA14A filed by Cumberland Pharmaceuticals Inc.
  • SEC1d
    Cumberland Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • PR1d
    Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
  • PR2d
    RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
  • PR8d
    CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE
  • INSIDER34d
    SEC Form 4 filed by Brown Martin S Jr
  • INSIDER34d
    SEC Form 4 filed by Galante Joseph C
  • INSIDER34d
    SEC Form 4 filed by Jones James
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022